In Spain, only 56% of people with obesity recognise that they have the disease. The finding shows a gap between health ...

In a recent trial, the obesity drug retatrutide helped patients lose up to 25% of their body weight over 80 weeks, with some ...

Can obesity pharmacotherapy modify osteoarthritis? A new review has weighed the pain relief against the structural evidence.

In research published in the journal Nature, McGill University researchers looked at the relationship between diet, the gut ...

Czech regulator SÚKL is weighing insurance cover for Wegovy for obese teens aged 12–18; treatment now costs 3,500 to over ...

The data on Novo's Wegovy pill suggests that patients may not need to take weekly injections forever, but can instead opt for ...

Breakthrough weight-loss drug helps diabetes patients lose a quarter of their body weight - Eli Lilly’s retatrutide works by ...

To the surprise of researchers, certain diets often considered "unhealthy" or "fattening" were associated with better ...

An emerging weight loss drug helped some obese people with type 2 diabetes to shed up to a quarter of their body weight while ...

Amylin-based petrelintide has achieved good results at Phase II for obesity, showing 8-11% weight loss and a good side effect profile.

Researchers published late-stage clinical trial data today for the latest obesity drug, retatrutide—expected to be the most ...

Every year, obesity and obesity-linked diseases cause 278,000 deaths and the loss of almost 8 million years of healthy life ...